BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Fluticasone propionate/salmeterol (Advair HFA) readouts · Ass
 etMemo
X-WR-CALDESC:Upcoming readouts of Fluticasone propionate/salmeterol (Advair
  HFA)\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06040268-4439@assetmemo.bio
DTSTAMP:20261121T010000Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:Fluticasone propionate/salmeterol (Advair HFA): Phase 1/2 readout e
 st. (NCT06040268)
DESCRIPTION:Fluticasone propionate/salmeterol (Advair HFA)\, phase 1/2.\nSt
 udy: Advair HFA in Healthy and HAPE Predisposed Subjects\nEstimated primar
 y completion: 1 December 2026. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/fluticasone-propionate-salmeterol-advair-hfa#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT06040268
URL:https://assetmemo.bio/drug/fluticasone-propionate-salmeterol-advair-hfa
 #upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
